FOXD4 and colorectal carcinoma: Mutations (indels) in diverse CRC samples revealed that MSI-high CRC largely harbor gained enhancers that selectively offer the privilege of recurrent growth of these tumors through increased affinity for putative transcription factor, e.g. Forkhead Box D4 (FOXD4) and target gene overexpression that is regulated by these enhancers (28).